(Q38311234)

2 September 2017

title

Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies (English)

1 reference

2 September 2017

0 references

1 reference

Olivia Belbin

4

0 references

Jordi Clarimón

object named as

Jordi Clarimón

7

0 references

author name string

Martí Colom-Cadena

1

1 reference

2 September 2017

Ellen Gelpi

2

1 reference

2 September 2017

Sara Charif

3

1 reference

2 September 2017

Rafael Blesa

5

1 reference

2 September 2017

Maria J Martí

6

1 reference

2 September 2017

Alberto Lleó

8

1 reference

2 September 2017

publication date

1 December 2013

1 reference

Journal of Neuropathology & Experimental Neurology

2 September 2017

published in

1 reference

2 September 2017

volume

72

1 reference

2 September 2017

issue

12

1 reference

2 September 2017

page(s)

1203-1212

1 reference

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Examining the mechanisms that link β-amyloid and α-synuclein pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Interface between tauopathies and synucleinopathies: A tale of two proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Co-occurrence of Parkinson's disease with progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Brain amyloid and cognition in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Striatal β-amyloid in dementia with Lewy bodies but not Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Neuropathology of non-motor features of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Neuropathologic substrates of Parkinson disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Correlations between cortical and subcortical tau pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

A powerful yeast model to investigate the synergistic interaction of α-synuclein and tau in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Genome-wide association study reveals genetic risk underlying Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Fiji: an open-source platform for biological-image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

HIF1A signaling selectively supports proliferation of breast cancer in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

A practical guide to evaluating colocalization in biological microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Early-onset familial lewy body dementia with extensive tauopathy: a clinical, genetic, and neuropathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Clinical, neuropathologic, and biochemical profile of the amyloid precursor protein I716F mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

NACP/alpha-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP717 gene mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Genetic analysis of pathways to Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Cell biology. A unifying role for prions in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Distinct α-synuclein strains differentially promote tau inclusions in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000018

10.1097/NEN.0000000000000018

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference